Paper6239683
Methods for amplifying the induction and expression of cytotoxic response in vitro to syngeneic and autologous freshly-isolated solid tumors of mice.
Kedar E and 2 others. Cancer Immunol Immunother, 1984. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Methods for amplifying the induction and expression of cytotoxic response in vitro to syngeneic and autologous freshly-isolated solid tumors of mice. Papers, record 6239683. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6239683
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytotoxicity, Immunologic | Major topic |
| Leukemia, Experimental | Major topic |
| Lung Neoplasms | Major topic |
| Lymphocytes | Major topic |
| Melanoma | Major topic |
| Animals | |
| DNA Replication | |
| Interleukin-2 | |
| Lymphocyte Activation | |
| Lymphocyte Culture Test, Mixed | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred C57BL | |
| Neoplasm Transplantation | |
| Transplantation, Autologous | |
| Transplantation, Isogeneic |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 5R01CA31859 | NCI NIH HHS | United States | R01CA031859 | PubMed and NIH |
Source NIH RePORTER
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6334139 | Immunotherapy of murine and human tumors in mice with lymphokines and interleukin-2-propagated lymphocytes. | J Biol Response Mod | 1984 | https://conductscience.org/library/papers/6334139 | PubMed |
| 2 | 6194216 | Activation of nonspecific killer cells by interleukin 2-containing supernatants. | J Immunol | 1983 | https://conductscience.org/library/papers/6194216 | PubMed |
| 3 | 314344 | Further characterization of suppressor lymphocytes induced by fetal calf serum in murine lymphoid cell cultures: comparison with in vitro-generated cytotoxic lymphocytes. | Cell Immunol | 1979 | https://conductscience.org/library/papers/314344 | PubMed |
| 4 | 307029 | T cell growth factor: parameters of production and a quantitative microassay for activity. | J Immunol | 1978 | https://conductscience.org/library/papers/307029 | PubMed |
| 5 | 6968789 | Thymoma production of T cell growth factor (Interleukin 2). | J Immunol | 1980 | https://conductscience.org/library/papers/6968789 | PubMed |
| 6 | 6176669 | Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. | J Exp Med | 1982 | https://conductscience.org/library/papers/6176669 | PubMed |
| 7 | 6602167 | Induction of cytotoxic T cell function requires sequential action of three different lymphokines. | J Immunol | 1983 | https://conductscience.org/library/papers/6602167 | PubMed |
| 8 | 659024 | In vitro generation of cytotoxicity against autologous human tumour biopsy cells. | Int J Cancer | 1978 | https://conductscience.org/library/papers/659024 | PubMed |
| 9 | 6984352 | Natural cell-mediated cytotoxicity in vitro and inhibition of tumor growth in vivo by murine lymphoid cells cultured with T cell growth factor (TCGF). | Cancer Immunol Immunother | 1982 | https://conductscience.org/library/papers/6984352 | PubMed |
| 10 | 6334140 | Suppression by tumor growth of T cell growth factor production in mouse lymphoid cell cultures. | J Biol Response Mod | 1984 | https://conductscience.org/library/papers/6334140 | PubMed |
| 11 | 6604229 | Reversible induction of natural killer cell activity in cloned murine cytotoxic T lymphocytes. | Nature | 1983 | https://conductscience.org/library/papers/6604229 | PubMed |
| 12 | 6224401 | The in vitro generation of effector lymphocytes and their employment in tumor immunotherapy. | Adv Cancer Res | 1983 | https://conductscience.org/library/papers/6224401 | PubMed |
| 13 | 4151339 | Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. | Adv Immunol | 1974 | https://conductscience.org/library/papers/4151339 | PubMed |
| 14 | 6223084 | LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures. | J Immunol | 1983 | https://conductscience.org/library/papers/6223084 | PubMed |
| 15 | 6978927 | Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses. | J Exp Med | 1982 | https://conductscience.org/library/papers/6978927 | PubMed |
| 16 | 6984388 | A rapid technique for isolation of viable tumor cells from solid tumors: use of the tumor cells for induction and measurement of cell-mediated cytotoxic responses. | Eur J Cancer Clin Oncol | 1982 | https://conductscience.org/library/papers/6984388 | PubMed |
| 17 | 6812964 | In vitro growth of cytotoxic human lymphocytes. V. Generation of allospecific cytotoxic lymphocytes to nonimmunogenic antigen by supplementation of in vitro sensitization with partially purified T-cell growth factor. | Cell Immunol | 1982 | https://conductscience.org/library/papers/6812964 | PubMed |
| 18 | 6159395 | Generation of cytotoxic lymphocytes to syngeneic tumor by using co-stimulator (Interleukin 2). | J Immunol | 1980 | https://conductscience.org/library/papers/6159395 | PubMed |
| 19 | 6444969 | Effects of adriamycin on the activity of mouse natural killer cells. | J Immunol | 1980 | https://conductscience.org/library/papers/6444969 | PubMed |
| 20 | 147948 | In vitro induction of cell-mediated immunity to murine leukemia cells. III. Effect of methanol extraction residue fraction of BCG on the generation of cytotoxic lymphocytes against leukemia. | J Natl Cancer Inst | 1978 | https://conductscience.org/library/papers/147948 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22358536 | Induction of auto-logous human cytotoxic T lymphocytes (CTL) from peripheral blood against tumor cells. | Cytotechnology | 1997 | https://conductscience.org/library/papers/22358536 | PubMed |
| 10391094 | Reduction of end-stage malignant glioma by injection with autologous cytotoxic T lymphocytes. | Jpn J Cancer Res | 1999 | https://conductscience.org/library/papers/10391094 | PubMed |
| 3499983 | Lysis of fresh murine mammary tumor cells by syngeneic natural killer cells and lymphokine-activated killer cells. | Cancer Immunol Immunother | 1987 | https://conductscience.org/library/papers/3499983 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6239683
GET https://conductscience.org/api/papers/v1/6239683/references?page=2